deltatrials
Completed PHASE3 INTERVENTIONAL 1-arm NCT00434811

Islet Transplantation in Type 1 Diabetes

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions Type 1 Diabetes Mellitus
Interventions Allogeneic Pancreatic Islet Cells Antithymocyte Globulin Basiliximab Etanercept Islet Transplantation Sirolimus Tacrolimus
Updated 9 times since 2017 Last updated: Jul 11, 2019 Started: Oct 31, 2006 Primary completion: Sep 30, 2012 Completion: May 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Type 1 Diabetes Mellitus and is currently completed. National Institute of Allergy and Infectious Diseases (NIAID) leads this study, which shows 9 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jul 2019 · 13 months · monthly snapshotCompleted~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshotCompleted~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotCompleted~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotCompleted~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Apr 2022 [monthly]

    Completed PHASE3

  5. Aug 2019 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 4 earlier versions

  1. Jul 2019 — Aug 2019 [monthly]

    Completed PHASE3

  2. Jun 2018 — Jul 2019 [monthly]

    Completed PHASE3

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations